- Home
- DAIO vs TPST Comparison
DAIO vs TPST Comparison
Compare DAIO & TPST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAIO
- TPST
- Stock Information
- Founded
- DAIO 1969
- TPST 2011
- Country
- DAIO United States
- TPST United States
- Employees
- DAIO N/A
- TPST N/A
- Industry
- DAIO Electrical Products
- TPST Biotechnology: Pharmaceutical Preparations
- Sector
- DAIO Industrials
- TPST Health Care
- Exchange
- DAIO Nasdaq
- TPST Nasdaq
- Market Cap
- DAIO 24.2M
- TPST 27.2M
- IPO Year
- DAIO N/A
- TPST N/A
- Fundamental
- Price
- DAIO $2.63
- TPST $0.97
- Analyst Decision
- DAIO Strong Buy
- TPST Strong Buy
- Analyst Count
- DAIO 1
- TPST 4
- Target Price
- DAIO $4.00
- TPST $20.00
- AVG Volume (30 Days)
- DAIO 26.1K
- TPST 3.3M
- Earning Date
- DAIO 10-24-2024
- TPST 11-12-2024
- Dividend Yield
- DAIO N/A
- TPST N/A
- EPS Growth
- DAIO N/A
- TPST N/A
- EPS
- DAIO N/A
- TPST N/A
- Revenue
- DAIO $23,458,000.00
- TPST N/A
- Revenue This Year
- DAIO N/A
- TPST N/A
- Revenue Next Year
- DAIO $4.17
- TPST N/A
- P/E Ratio
- DAIO N/A
- TPST N/A
- Revenue Growth
- DAIO N/A
- TPST N/A
- 52 Week Low
- DAIO $2.29
- TPST $0.86
- 52 Week High
- DAIO $3.99
- TPST $6.00
- Technical
- Relative Strength Index (RSI)
- DAIO 53.89
- TPST 42.46
- Support Level
- DAIO $2.54
- TPST $0.94
- Resistance Level
- DAIO $2.70
- TPST $1.16
- Average True Range (ATR)
- DAIO 0.11
- TPST 0.09
- MACD
- DAIO -0.00
- TPST 0.01
- Stochastic Oscillator
- DAIO 50.00
- TPST 39.34
About DAIO Data I/O Corporation
Data I/O Corp is a provider of programming, security deployment, security provisioning and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in United States, Europe and Rest of the world.
About TPST Tempest Therapeutics Inc.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.